Form 4 for OPRX OptimizeRx Corp
Accepted 2023-04-03 00:00:00 ET · period of report 2023-03-31 · accession 0001628280-23-010319 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-03 | 2023-03-31 | OPRX | Vos Ellen O'Connor | Dir | M - OptEx | $0.00 | +657 | 34.8K | +2% | $0 |
| D | 2023-04-03 | 2023-03-31 | OPRX | Vos Ellen O'Connor | Dir | M - OptEx | $0.00 | -657 | 657 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | M | A | 657 | $0.00 | 34,790 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2023-03-31 | M | D | 657 | $0.00 | 657 | D | — · — to — | 657 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On March 30, 2022 the reporting person was granted 657 restricted stock units which vested in full on March 30, 2023. |